CAD 0.07
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 37.48 Million CAD | -0.87% |
2022 | 45.42 Million CAD | -5.32% |
2021 | 47.98 Million CAD | 21.87% |
2020 | 39.37 Million CAD | 36.26% |
2019 | 28.89 Million CAD | 211.12% |
2018 | -26 Million CAD | -93077.19% |
2017 | 27.96 Thousand CAD | 119.12% |
2016 | 12.76 Thousand CAD | 23305.45% |
2015 | -55.00 CAD | 98.02% |
2014 | -2780.00 CAD | -102.51% |
2013 | 110.76 Thousand CAD | 737.27% |
2012 | -17.38 Thousand CAD | -76.96% |
2011 | -9822.00 CAD | 64.27% |
2010 | -27.49 Thousand CAD | 88.04% |
2009 | -229.81 Thousand CAD | -1072.44% |
2008 | 23.63 Thousand CAD | 109.59% |
2007 | -246.41 Thousand CAD | -123.44% |
2006 | 1.05 Million CAD | 7.09% |
2005 | 981.47 Thousand CAD | 1057.05% |
2004 | -102.55 Thousand CAD | -294.34% |
2003 | -26 Thousand CAD | 82.3% |
2002 | -146.96 Thousand CAD | 29.11% |
2001 | -207.31 Thousand CAD | 20.7% |
2000 | -261.44 Thousand CAD | -36826.84% |
1999 | -708.00 CAD | -19.59% |
1998 | -592.00 CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 43.85 Million CAD | -1.98% |
2024 Q1 | 44.73 Million CAD | -0.66% |
2023 Q3 | 43.98 Million CAD | -2.21% |
2023 FY | 45.03 Million CAD | -0.87% |
2023 Q2 | 44.97 Million CAD | -0.95% |
2023 Q1 | 45.4 Million CAD | -0.04% |
2023 Q4 | 45.03 Million CAD | 2.39% |
2022 Q4 | 45.42 Million CAD | 2.53% |
2022 Q1 | 46.57 Million CAD | -2.94% |
2022 Q2 | 45.65 Million CAD | -1.96% |
2022 FY | 45.42 Million CAD | -5.32% |
2022 Q3 | 44.3 Million CAD | -2.95% |
2021 Q2 | 47.28 Million CAD | 8.31% |
2021 Q1 | 43.65 Million CAD | 10.88% |
2021 FY | 47.98 Million CAD | 21.87% |
2021 Q4 | 47.98 Million CAD | 16.17% |
2021 Q3 | 41.3 Million CAD | -12.65% |
2020 Q1 | 36.73 Million CAD | 27.15% |
2020 Q4 | 39.37 Million CAD | -3.0% |
2020 Q3 | 40.58 Million CAD | 5.51% |
2020 FY | 39.37 Million CAD | 36.26% |
2020 Q2 | 38.46 Million CAD | 4.71% |
2019 Q2 | 6.51 Million CAD | 142.85% |
2019 Q1 | -15.2 Million CAD | 0.0% |
2019 FY | 28.89 Million CAD | 211.12% |
2019 Q4 | 28.89 Million CAD | 93.8% |
2019 Q3 | 14.9 Million CAD | 128.81% |
2018 Q2 | -424.55 Thousand CAD | 0.99% |
2018 Q3 | -187.66 Thousand CAD | 55.8% |
2018 Q1 | -428.81 Thousand CAD | -1198.61% |
2018 FY | -26 Million CAD | -93077.19% |
2017 Q2 | 27.96 Thousand CAD | 9.39% |
2017 Q4 | 39.03 Thousand CAD | 30.72% |
2017 FY | 27.96 Thousand CAD | 119.12% |
2017 Q1 | 25.56 Thousand CAD | 5.4% |
2017 Q3 | 29.86 Thousand CAD | 6.77% |
2016 Q4 | 24.25 Thousand CAD | 15.48% |
2016 FY | 12.76 Thousand CAD | 23305.45% |
2016 Q3 | 21 Thousand CAD | 64.56% |
2016 Q2 | 12.76 Thousand CAD | -0.19% |
2016 Q1 | 12.78 Thousand CAD | 29.31% |
2015 Q3 | 8350.00 CAD | 15281.82% |
2015 Q4 | 9889.00 CAD | 18.43% |
2015 Q2 | -55.00 CAD | -120.3% |
2015 Q1 | 271.00 CAD | -72.38% |
2015 FY | -55.00 CAD | 98.02% |
2014 Q3 | 2677.00 CAD | 196.29% |
2014 Q2 | -2780.00 CAD | -102.78% |
2014 FY | -2780.00 CAD | -102.51% |
2014 Q1 | 100.09 Thousand CAD | 105.87% |
2014 Q4 | 981.00 CAD | -63.35% |
2013 Q2 | 110.76 Thousand CAD | 12.33% |
2013 Q1 | 98.6 Thousand CAD | 19.53% |
2013 Q3 | 12.01 Thousand CAD | -89.15% |
2013 Q4 | 48.62 Thousand CAD | 304.59% |
2013 FY | 110.76 Thousand CAD | 737.27% |
2012 Q3 | -7088.00 CAD | 59.22% |
2012 Q4 | 82.49 Thousand CAD | 1263.88% |
2012 FY | -17.38 Thousand CAD | -76.96% |
2012 Q1 | -11.43 Thousand CAD | 26.93% |
2012 Q2 | -17.38 Thousand CAD | -52.01% |
2011 Q3 | -4903.00 CAD | 50.08% |
2011 Q4 | -15.64 Thousand CAD | -219.17% |
2011 FY | -9822.00 CAD | 64.27% |
2011 Q1 | -20.6 Thousand CAD | -805.58% |
2011 Q2 | -9822.00 CAD | 52.33% |
2010 Q3 | -11.48 Thousand CAD | 58.21% |
2010 Q4 | -2275.00 CAD | 80.2% |
2010 FY | -27.49 Thousand CAD | 88.04% |
2010 Q2 | -27.49 Thousand CAD | 60.29% |
2010 Q1 | -69.22 Thousand CAD | -330.79% |
2009 Q2 | -229.81 Thousand CAD | 18.66% |
2009 FY | -229.81 Thousand CAD | -1072.44% |
2009 Q4 | -16.07 Thousand CAD | 92.51% |
2009 Q1 | -282.53 Thousand CAD | 5.95% |
2009 Q3 | -214.54 Thousand CAD | 6.65% |
2008 Q2 | 23.63 Thousand CAD | 110.4% |
2008 Q4 | -300.4 Thousand CAD | -300.56% |
2008 Q3 | 149.78 Thousand CAD | 533.79% |
2008 Q1 | -227.29 Thousand CAD | -212.2% |
2008 FY | 23.63 Thousand CAD | 109.59% |
2007 Q1 | -33.96 Thousand CAD | -108.29% |
2007 Q4 | 202.56 Thousand CAD | 432.32% |
2007 Q3 | 38.05 Thousand CAD | 115.44% |
2007 Q2 | -246.41 Thousand CAD | -625.59% |
2007 FY | -246.41 Thousand CAD | -123.44% |
2006 Q2 | 1.05 Million CAD | 18.75% |
2006 Q3 | 1.19 Million CAD | 13.81% |
2006 Q1 | 885.15 Thousand CAD | -26.08% |
2006 Q4 | 409.79 Thousand CAD | -65.74% |
2006 FY | 1.05 Million CAD | 7.09% |
2005 Q3 | 985.98 Thousand CAD | 0.46% |
2005 Q2 | 981.47 Thousand CAD | -20.31% |
2005 FY | 981.47 Thousand CAD | 1057.05% |
2005 Q4 | 1.19 Million CAD | 21.44% |
2005 Q1 | 1.23 Million CAD | 38.71% |
2004 Q1 | -55.33 Thousand CAD | -961.25% |
2004 Q2 | -102.55 Thousand CAD | -85.33% |
2004 Q4 | 887.88 Thousand CAD | 157.56% |
2004 FY | -102.55 Thousand CAD | -294.34% |
2004 Q3 | -1.54 Million CAD | -1404.05% |
2003 FY | -26 Thousand CAD | 82.3% |
2003 Q4 | 6425.00 CAD | -61.4% |
2003 Q3 | 16.64 Thousand CAD | 164.0% |
2003 Q2 | -26 Thousand CAD | 67.64% |
2003 Q1 | -80.36 Thousand CAD | 20.11% |
2002 Q4 | -100.59 Thousand CAD | 25.59% |
2002 Q3 | -135.19 Thousand CAD | 8.01% |
2002 Q2 | -146.96 Thousand CAD | 4.49% |
2002 FY | -146.96 Thousand CAD | 29.11% |
2002 Q1 | -153.87 Thousand CAD | 9.32% |
2001 Q1 | -222.95 Thousand CAD | 0.0% |
2001 FY | -207.31 Thousand CAD | 20.7% |
2001 Q4 | -169.68 Thousand CAD | 13.18% |
2001 Q3 | -195.45 Thousand CAD | 5.72% |
2001 Q2 | -207.31 Thousand CAD | 7.01% |
2000 Q2 | -261.44 Thousand CAD | 0.0% |
2000 FY | -261.44 Thousand CAD | -36826.84% |
2000 Q3 | -251.42 Thousand CAD | 3.83% |
1999 Q3 | 114.07 Thousand CAD | 0.0% |
1999 FY | -708.00 CAD | -19.59% |
1998 FY | -592.00 CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 4.89 Million CAD | -665.963% |
CanadaBis Capital Inc. | 4.08 Million CAD | -817.776% |
Delivra Health Brands Inc. | -2.17 Million CAD | 1824.942% |
Entourage Health Corp. | 150.32 Million CAD | 75.066% |
Lifeist Wellness Inc. | -188.12 Thousand CAD | 20024.095% |
Cannara Biotech Inc. | 41.51 Million CAD | 9.708% |
Medicure Inc. | -5.82 Million CAD | 743.485% |
PharmaCielo Ltd. | 18.24 Million CAD | -105.426% |
Rubicon Organics Inc. | 475.37 Thousand CAD | -7784.983% |
BioSyent Inc. | -3.68 Million CAD | 1117.186% |
Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | -98760.609% |